SCHEMBL12674841

SCHEMBL12674841

Fc1ccc(CNc2ncc(Cc3c[nH]c4ncc(F)cc34)cn2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 10/20 0.60
CYP3A4 P08684 10/20 0.60
CYP2C19 P33261 5/20 0.57
CYP2D6 P10635 1/20 0.52
CSF1R P07333 2/20 0.48
MET P08581 1/20 0.47
LCK P06239 1/20 0.47
PGR P06401 1/20 0.47
CHRM2 P08172 1/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
PDGFRB P09619 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
KIT P10721 1/20 0.47
CHRM1 P11229 1/20 0.47
PDGFRA P16234 1/20 0.47
FLT1 P17948 1/20 0.47
DRD1 P21728 1/20 0.47
TBXA2R P21731 1/20 0.47
SLC6A2 P23975 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1267539 0.90 CYP2C9 (0.70) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R
SCHEMBL1882678 0.89 CYP3A4 (0.64) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R
SCHEMBL1885510 0.87 CYP3A4 (0.59) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R
SCHEMBL1881996 0.87 CYP2C19 (0.64) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R
SCHEMBL1891900 0.86 CYP2C9 (0.79) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R
SCHEMBL1886350 0.81 CYP3A4 (0.83) CYP2C9CYP3A4CYP2C19CSF1RKIT
SCHEMBL1889798 0.81 CYP2C9 (0.50) CYP2C9CYP3A4CYP2C19CYP2D6MET
SCHEMBL1891153 0.81 CYP2C9 (0.48) CYP2C9CYP3A4CYP2C19CYP2D6MET
SCHEMBL1882746 0.81 CYP3A4 (0.88) CYP2C9CYP3A4CYP2C19CSF1RKIT
SCHEMBL1266686 0.81 CYP2C9 (0.74) CYP2C9CYP3A4CYP2C19CYP2D6CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057022-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-05-12 WO disclosed